These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5845223)

  • 1. Candidial vaginitis associated with the use of oral progestational agents.
    Walsh H; Hildebrandt RJ; Prystowsky H
    Am J Obstet Gynecol; 1965 Nov; 93(6):904-5. PubMed ID: 5845223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral progestational agents as a cause of Candida vaginitis.
    Walsh H; Hildebrandt RJ; Prystowsky H
    Am J Obstet Gynecol; 1968 Aug; 101(7):991-3. PubMed ID: 5659957
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonbarrier contraceptives and vaginitis and vaginosis.
    Roy S
    Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 2):1240-4. PubMed ID: 1951581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protective influence of progestogen only contraception against vaginal moniliasis.
    Toppozada M; Onsy FA; Fares E; Amir S; Shaala S
    Contraception; 1979 Aug; 20(2):99-103. PubMed ID: 487820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of genital infections in a family-planning clinic. 1. Microbiological findings and their association with vaginal symptoms.
    Riordan T; Macaulay ME; James JM; Leventhall PA; Morris EM; Neal BR; Rowland J; Evans BM
    Epidemiol Infect; 1990 Feb; 104(1):47-53. PubMed ID: 2307184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous progestins and breast cancer.
    Stanford JL; Thomas DB
    Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vulvovaginal candidosis and oral contraceptives.
    Pumpianski R; Ganor S
    Mykosen; 1974 Aug; 17(8):173-8. PubMed ID: 4610385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 'pill' may inhibit early cancer, study suggests.
    JAMA; 1972 May; 220(6):775-80. PubMed ID: 12275891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of Gardnerella vaginalis, Trichomonas vaginalis and Candida albicans in the cytology clinic at Ibadan, Nigeria.
    Konje JC; Otolorin EO; Ogunniyi JO; Obisesan KA; Ladipo OA
    Afr J Med Med Sci; 1991 Mar; 20(1):29-34. PubMed ID: 1905467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of contraceptive methods on the onset of symptomatic vulvovaginal candidiasis within the menstrual cycle.
    Nelson AL
    Am J Obstet Gynecol; 1997 Jun; 176(6):1376-80. PubMed ID: 9215201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on development of a vaginal preparation providing both prophylaxis against venereal disease, other genital infections and contraception. 3. In vitro effect of vaginal contraceptive and selected vaginal preparations of Candida albicans and Trichomonas vaginalis.
    Singh B; Cutler JC; Utidjian HM
    Contraception; 1972 May; 5(5):401-11. PubMed ID: 4568277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Office laboratory diagnosis of vaginitis. Clinician-performed tests compared with a rapid nucleic acid hybridization test.
    Ferris DG; Hendrich J; Payne PM; Getts A; Rassekh R; Mathis D; Litaker MS
    J Fam Pract; 1995 Dec; 41(6):575-81. PubMed ID: 7500067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of Gardnerella vaginalis, Candida albicans, and Trichomonas vaginalis infections of the vagina.
    Reed BD; Huck W; Zazove P
    J Fam Pract; 1989 Jun; 28(6):673-80. PubMed ID: 2656903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of aerobic vaginitis and its association to vaginal candidiasis, trichomonas vaginitis and bacterial vaginosis.
    Jahic M; Mulavdic M; Nurkic J; Jahic E; Nurkic M
    Med Arch; 2013 Dec; 67(6):428-30. PubMed ID: 25568514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of Candida albicans in women using oral contraceptives.
    Jensen HK; Hansen PA; Blom J
    Acta Obstet Gynecol Scand; 1970; 49(3):293-6. PubMed ID: 5519505
    [No Abstract]   [Full Text] [Related]  

  • 18. [Oral estroprogestins as a cause of vaginal mycosis].
    Gacci G; Romano GP
    Minerva Ginecol; 1969 Sep; 21(17):1111-3. PubMed ID: 5404420
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence of vaginal infections with bacterial vaginosis, Trichomonas vaginalis and Candida albicans among pregnant women at the Port Moresby General Hospital Antenatal Clinic.
    Klufio CA; Amoa AB; Delamare O; Hombhanje M; Kariwiga G; Igo J
    P N G Med J; 1995 Sep; 38(3):163-71. PubMed ID: 9522855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis.
    Barbone F; Austin H; Louv WC; Alexander WJ
    Am J Obstet Gynecol; 1990 Aug; 163(2):510-4. PubMed ID: 2167008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.